Table of Contents

February 13, 2003
Volume 46, Issue 4
Pages 445-653

Perspectives

Ernest Guenther Award in Chemistry of Natural Products. Amphibian Skin:  A Remarkable Source of Biologically Active Arthropod Alkaloids

pp 445–452
Publication Date (Web): December 31, 2002 (Perspective)
DOI: 10.1021/jm0204845

Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected Cells

pp 453–456
Publication Date (Web): January 09, 2003 (Letter)
DOI: 10.1021/jm025553u

Substituted Pyrazolopyridopyridazines as Orally Bioavailable Potent and Selective PDE5 Inhibitors:  Potential Agents for Treatment of Erectile Dysfunction

pp 457–460
Publication Date (Web): January 08, 2003 (Letter)
DOI: 10.1021/jm0256068

Articles

Metabolism-Directed Optimization of 3-Aminopyrazinone Acetamide Thrombin Inhibitors. Development of an Orally Bioavailable Series Containing P1 and P3 Pyridines

pp 461–473
Publication Date (Web): January 08, 2003 (Article)
DOI: 10.1021/jm020311f

Structure-Based de Novo Design, Synthesis, and Biological Evaluation of Non-Azole Inhibitors Specific for Lanosterol 14α-Demethylase of Fungi

pp 474–485
Publication Date (Web): January 18, 2003 (Article)
DOI: 10.1021/jm020362c

Identification, Synthesis, and Activity of Novel Blockers of the Voltage-Gated Potassium Channel Kv1.5

pp 486–498
Publication Date (Web): January 21, 2003 (Article)
DOI: 10.1021/jm0210461

Surflex:  Fully Automatic Flexible Molecular Docking Using a Molecular Similarity-Based Search Engine

pp 499–511
Publication Date (Web): January 21, 2003 (Article)
DOI: 10.1021/jm020406h

3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 1. Design, Synthesis, Biological Evaluation, and Binding Mode Studies Performed through Three Different Docking Procedures

pp 512–524
Publication Date (Web): January 21, 2003 (Article)
DOI: 10.1021/jm021070e

Antineoplastic Agents. 487. Synthesis and Biological Evaluation of the Antineoplastic Agent 3,4-Methylenedioxy-5,4‘-dimethoxy-3‘-amino-Z-stilbene and Derived Amino Acid Amides

pp 525–531
Publication Date (Web): January 10, 2003 (Article)
DOI: 10.1021/jm020204l

4-Substituted 4-Hydroxycyclohexa-2,5-dien-1-ones with Selective Activities against Colon and Renal Cancer Cell Lines

pp 532–541
Publication Date (Web): January 21, 2003 (Article)
DOI: 10.1021/jm020984y

Synthesis and in Vitro and in Vivo Antimalarial Activity of N1-(7-Chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine Derivatives

pp 542–557
Publication Date (Web): January 21, 2003 (Article)
DOI: 10.1021/jm020960r

Absorption Classification of Oral Drugs Based on Molecular Surface Properties

pp 558–570
Publication Date (Web): January 11, 2003 (Article)
DOI: 10.1021/jm020986i

Design, Synthesis, and Biological Evaluation of a Series of Fluoroquinoanthroxazines with Contrasting Dual Mechanisms of Action against Topoisomerase II and G-Quadruplexes

pp 571–583
Publication Date (Web): January 04, 2003 (Article)
DOI: 10.1021/jm0203377

Orally Active Analogues of the Dopaminergic Prodrug 6-(N,N-Di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one:  Synthesis and Pharmacological Activity

pp 584–590
Publication Date (Web): January 09, 2003 (Article)
DOI: 10.1021/jm020990u

Design, Synthesis, and Biological Activities of Classical N-{4-[2-(2-Amino-4-ethylpyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-l-glutamic Acid and Its 6-Methyl Derivative as Potential Dual Inhibitors of Thymidylate Synthase and Dihydrofolate Reductase and as Potential Antitumor Agents1

pp 591–600
Publication Date (Web): January 21, 2003 (Article)
DOI: 10.1021/jm0203534

Preparation of 7-Substituted Ginkgolide Derivatives:  Potent Platelet Activating Factor (PAF) Receptor Antagonists

pp 601–608
Publication Date (Web): January 21, 2003 (Article)
DOI: 10.1021/jm0203985

Syntheses and Antiproliferative Activities of 7-Azarebeccamycin Analogues Bearing One 7-Azaindole Moiety

pp 609–622
Publication Date (Web): January 18, 2003 (Article)
DOI: 10.1021/jm0210055

3-(αR)-α-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)- N-alkyl-N-arylbenzamides:  Potent, Non-Peptidic Agonists of Both the μ and δ Opioid Receptors

pp 623–633
Publication Date (Web): January 21, 2003 (Article)
DOI: 10.1021/jm020395s

Brief Articles

CC-1065 Analogues Bearing Different DNA-Binding Subunits:  Synthesis, Antitumor Activity, and Preliminary Toxicity Study

pp 634–637
Publication Date (Web): January 11, 2003 (Brief Article)
DOI: 10.1021/jm0203433

New Semisynthetic Quassinoids with in Vivo Antimalarial Activity

pp 638–641
Publication Date (Web): January 18, 2003 (Brief Article)
DOI: 10.1021/jm0201971

Synthesis, Structure−Activity Relationship, and Evaluation of SR141716 Analogues:  Development of Central Cannabinoid Receptor Ligands with Lower Lipophilicity

pp 642–645
Publication Date (Web): January 18, 2003 (Brief Article)
DOI: 10.1021/jm020157x

Synthesis and Structure−Affinity Relationships of 1-[ω-(4-Aryl-1-piperazinyl)alkyl]-1-aryl Ketones as 5-HT7 Receptor Ligands

pp 646–649
Publication Date (Web): January 18, 2003 (Brief Article)
DOI: 10.1021/jm020994z

Book Reviews

New Drugs 2001. Including All Drugs Approved in 2000 and 2001 Edited by G. W. A. Milne. Ashgate Publishing Company, Burlington, VT. 2002. xxiii + 154 pp. 12.5 × 25 cm. ISBN 0-566-08516-X. $90.00.

p 650
Publication Date (Web): January 10, 2003 (Book Review)
DOI: 10.1021/jm0204744

Scientists Must Speak By D. Eric Walters and Gale Climenson Walters. Routledge, London and New York. 2002. xii + 132 pp. 14 × 21.5 cm. ISBN 0-415-28028-1. $18.95 (paperback).

p 650
Publication Date (Web): January 11, 2003 (Book Review)
DOI: 10.1021/jm020552n
p 651
Publication Date (Web): January 17, 2003 (Book Review)
DOI: 10.1021/jm020553f

Additions and Corrections

Structure−Activity Studies on Anticonvulsant Sugar Sulfamates Related to Topiramate. Enhanced Potency with Cyclic Sulfate Derivatives.

p 652
Publication Date (Web): January 18, 2003 (Addition/Correction)
DOI: 10.1021/jm020527h

New Approach to Pharmacophore Mapping and QSAR Analysis Using Inductive Logic Programming. Application to Thermolysin Inhibitors and Glycogen Phosphorylase b Inhibitors

p 653
Publication Date (Web): January 15, 2003 (Addition/Correction)
DOI: 10.1021/jm020948z